Login | Register

FDA Investigates Safety Of Type 2 Diabetes Drugs Januvia And Byetta

The U.S. Food and Drug Administration is investigating whether or not the Type 2 Diabetes drugs Januvia (from Merck) and Byetta (from Bristol-Myers Squibb) are associated with an increased risk of developing pancreatic cancer. Close to 25 million people in the United States have diabetes, costing the country an estimated $245 billion a year...

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *